Flenox (enoxaparin sodium) solution for injections 4000ME/0.4 ml. №10 syringe


Manufacturer: Ukraine



Prevention of venous thromboembolism in surgical interventions that are accompanied by a moderate and high thrombogenic risk; prevention of deep vein thrombosis in patients who are on bed rest due to acute therapeutic diseases: NYHA class i or IV heart failure, acute respiratory failure, acute infectious or rheumatic disease, if there is at least one other risk factor for venous thromboembolism; prevention of thrombosis in the extracorporeal circulation circuit during hemodialysis (the procedure lasts approximately 4 hours on average); treatment of diagnosed deep vein thrombosis that is accompanied or not accompanied by pulmonary embolism and does not have severe clinical symptoms, except for pulmonary embolism that requires treatment with a thrombolytic agent or surgery; treatment of unstable angina and acute myocardial infarction without q wave in combination with acetylsalicylic acid; treatment of acute myocardial infarction with elevation / elevation of the ST segment in combination with a thrombolytic agent in patients who may continue to use coronary angioplasty, as well as in patients who do not undergo this procedure.